XML 27 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
EQUITY-BASED COMPENSATION
9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EQUITY-BASED COMPENSATION
EQUITY-BASED COMPENSATION
 
Our currently outstanding equity-based awards were issued under the Equity Plan which provides for the granting of stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, and other equity-based awards or incentive awards.
 
Stock options granted may be either incentive stock options or non-qualified stock options. Vesting terms may vary with each grant, and stock option terms are generally five to ten years. We have outstanding equity-based awards in the form of stock options and restricted stock awards. All of our outstanding equity-based awards are classified as equity awards.
 
Stock Options Granted Under our Equity Plan

During the three months ended September 30, 2016, we completed a net issuance of 37,684 shares of common stock upon the cashless exercise of outstanding stock options with an exercise price of $9.75 per share. As of September 30, 2016, the number of stock options outstanding and exercisable totaled 235,000 with a weighted average exercise price of $9.75 per share, weighted average contractual term of 4.4 years and an aggregate intrinsic value of $0.8 million.
  
Time-Based Restricted Stock Awards Made Pursuant to Our Equity Plan
 
On February 24, 2016, we granted time-based restricted stock awards for 22,010 shares of common stock to certain of our non-executive employees. The awards vest over a four-year period based on continued service (20% on March 9, 2017, 2018 and 2019, and 40% on March 9, 2020).  On March 8, 2016, we granted time-based restricted stock awards for 169,707 shares of common stock to our executive officers. The awards vest 25% on March 9, 2017, 25% on March 9, 2018 and 50% on March 9, 2019, based on continuous service through the vesting dates or in certain circumstances upon a change in control. On September 2, 2016, we granted time-based restricted stock awards for 406 shares of common stock to certain of our non-executive employees. The awards vest over a four-year period based on continued service (20% on September 3, 2017, 2018 and 2019, and 40% on September 3, 2020). 

On March 3, 2015, we granted time-based restricted stock awards for 149,410 shares of common stock to our executive officers and management. With the exception of 37,230 shares that cliff vest in total on March 9, 2018 based on continuous service through the vesting date or a change in control, 25% of the awards vested on March 9, 2016 and the remaining awards vest 25% on March 9, 2017 and 50% on March 9, 2018, unless vesting is accelerated upon a change in control.

On April 24, 2015, we granted a time-based restricted stock award for 16,930 shares of common stock to one of our executive officers.  This award vested during the third quarter of 2015.

The holders of these grants have the right to vote the related shares of common stock and receive all dividends declared and paid whether or not vested. The fair value of time-based restricted stock awards is calculated based on the market value of our common stock on the date of grant.
 
The following table summarizes time-based restricted stock award activity under the Equity Plan for the nine months ended September 30, 2016:
 
 
 
Number of Shares
 
Weighted Average
Grant Date Fair Value
 
Aggregate
Current Value
 
 
 
 
(per share)
 
(in thousands)
Non-vested December 31, 2015
 
250,011

 
$
12.03

 
$
2,988

Granted
 
192,123

 
11.36

 
 

Vested
 
(82,869
)
 
11.06

 
 

Forfeited
 
(406
)
 
10.27

 
 

Outstanding at September 30, 2016
 
358,859

 
$
11.90

 
$
4,723


 
Performance-Based Restricted Stock Awards Made Pursuant to Our Equity Plan

On March 8, 2016, we granted performance-based restricted stock awards for 254,563 shares of common stock to our executive officers. Our performance-based restricted stock awards are market-based awards and are accounted for based on the fair value of our common stock on the grant date. The fair value of the performance-based restricted stock awards granted was estimated using a Monte Carlo simulation valuation model. These awards generally vest based on our percentile ranking within the SNL U.S. REIT Hotel Index at the end of the period beginning on March 8, 2016 and ending on the earlier of March 8, 2019 or upon a change in control.  The awards require continued service during the measurement period and are subject to the other conditions described in the Equity Plan or award document.

On March 3, 2015, we granted performance-based restricted stock awards for 154,505 shares of common stock to certain of our executive officers. The fair value of the performance-based restricted stock awards granted was estimated using a Monte Carlo simulation valuation model. These awards vest based on our percentile ranking within the SNL U.S. REIT Hotel Index at the end of the period beginning on January 1, 2015 and ending on the earlier of December 31, 2017, or upon a change in control.  The awards require continued service during the measurement period and are subject to the other conditions described in the Equity Plan or award document.
 
The number of shares the executive officers may earn under these awards range from zero shares to twice the number of shares granted based on our percentile ranking within the index at the end of the measurement period. In addition, a portion of the performance-based shares may be earned based on the Company's absolute total shareholder return calculated during the performance period. The holders of these grants have the right to vote the granted shares of common stock and any dividends declared will be accumulated and will be subject to the same vesting conditions as the awards.  Further, if additional shares are earned based on our percentile ranking within the index, dividend payments will be issued as if the additional shares had been held throughout the measurement period.
 
The following table summarizes performance-based restricted stock activity under the Equity Plan for the nine months ended September 30, 2016:
 
 
 
Number of Shares
 
Weighted Average
Grant Date Fair Value (1)
 
Aggregate
Current Value
 
 
 
 
(per share)
 
(in thousands)
Non-vested December 31, 2015
 
308,367

 
$
12.95

 
$
3,685

Granted
 
254,563

 
13.77

 
 

Vested
 
(113,903
)
 
7.10

 
 

Forfeited
 

 

 
 

Outstanding at September 30, 2016
 
449,027

 
$
14.90

 
$
5,909



(1) The amounts included in this column represent the expected future value of the performance-based restricted stock awards calculated using the Monte Carlo simulation valuation model.

Director Stock Awards Made Pursuant to Our Equity Plan
 
Our non-employee directors have the option to receive shares of our common stock in lieu of cash for their director fees. During the nine months ended September 30, 2016, we issued 5,851 shares of our common stock in lieu of cash for director fees and we made an annual grant of 32,180 shares of common stock to our independent directors.  The fair value of director stock awards is calculated based on the market value of our common stock on the date of grant.
 
Equity-Based Compensation Expense
 
Equity-based compensation expense included in Corporate General and Administrative expenses in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2016 and 2015 was as follows (in thousands):
 
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2016
 
2015
 
2016
 
2015
Stock options
 
$

 
$
256

 
$
55

 
$
551

Time-based restricted stock
 
419

 
820

 
1,176

 
1,396

Performance-based restricted stock
 
576

 
864

 
1,532

 
1,568

Director stock
 
25

 
20

 
439

 
453

 
 
$
1,020

 
$
1,960

 
$
3,202

 
$
3,968


 
We recognize equity-based compensation expense ratably over the vesting period of the equity awards granted. Unrecognized equity-based compensation expense for all non-vested awards was $7.1 million at September 30, 2016 as follows (in thousands):
 
 
 
Total
 
2016
 
2017
 
2018
 
2019
 
2020
Time-based restricted stock
 
$
2,920

 
$
420

 
$
1,506

 
$
819

 
$
165

 
$
10

Performance-based restricted stock
 
4,130

 
575

 
2,192

 
1,168

 
195

 

 
 
$
7,050

 
$
995

 
$
3,698

 
$
1,987

 
$
360

 
$
10